FDA warns of rare vision-loss side effect from GLP-1 drugs

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.

• Nov 9

More people now use GLP-1s to lose weight than for other health issues

Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon.

• Oct 22

Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?

The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."

• Sep 24

Can taking weight-loss drugs help you get hired? Yes, if you're a woman.

Going on GLP-1 drugs significantly boosted unemployed women's chances of finding a job, according to a Harvard economist.

• Aug 14

GLP-1s are linked to a 17% drop in worker sick leave, new study finds

Here's how weight-loss drugs like Ozempic and Wegovy could reduce worker illness and save companies money.

• Jul 21

Novo Nordisk sues Eli Lilly, accusing it of false advertising

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

• Jul 21

Here's what to know about Medicare's new GLP-1 weight-loss drug program

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

• Jun 29